This study therefore provides a key transcriptional roadmap of in vitro cardiac differentiation at singlecell resolution, revealing fundamental mechanisms underlying heart development and differentiation of hPSC-derived cardiomyocytes.
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In Brief
Friedman et al. performed single-cell transcriptional analysis over a time course of in vitro cardiac differentiation from human pluripotent stem cells. They utilized these data to identify the requirement of hypertrophic stimuli for expression of a cardiac regulatory gene, HOPX, to generate cardiomyocytes more accurately reflecting in vivo heart development.
SUMMARY
Cardiac differentiation of human pluripotent stem cells (hPSCs) requires orchestration of dynamic gene regulatory networks during stepwise fate transitions but often generates immature cell types that do not fully recapitulate properties of their adult counterparts, suggesting incomplete activation of key transcriptional networks. We performed extensive single-cell transcriptomic analyses to map fate choices and gene expression programs during cardiac differentiation of hPSCs and identified strategies to improve in vitro cardiomyocyte differentiation. Utilizing genetic gain-and loss-of-function approaches, we found that hypertrophic signaling is not effectively activated during monolayer-based cardiac differentiation, thereby preventing expression of HOPX and its activation of downstream genes that govern late stages of cardiomyocyte maturation. This study therefore provides a key transcriptional roadmap of in vitro cardiac differentiation at singlecell resolution, revealing fundamental mechanisms underlying heart development and differentiation of hPSC-derived cardiomyocytes.
INTRODUCTION
Studies of cardiac development at single-cell resolution have provided valuable insights into cell diversity and genetic regulation of cardiovascular differentiation and morphogenesis in vivo (DeLaughter et al., 2016; Li et al., 2016) . Human pluripotent stem cells are a key model system to study human cardiovascular developmental biology (Murry and Keller, 2008) . However, it is well understood that cardiac differentiation in vitro does not generate cardiomyocytes with the transcriptional profile, cellular diversity, morphometry, or functional maturity of adult in-vivoderived cardiomyocytes (Yang et al., 2014) . The fidelity by which cardiac-directed differentiation in vitro recapitulates the transcriptional programs governing diverse cell fates generated in vivo has not been well characterized.
In this study, we report RNA sequencing data captured from more than 40,000 single cells navigating stage-specific transitions through in vitro cardiac-directed differentiation from pluripotency using an established small-molecule Wnt modulation protocol (Burridge et al., 2014; Lian et al., 2012) . In coordination with a companion paper , we utilize the power of this dataset to expand our understanding of stem cell-directed differentiation as a platform to study cardiovascular development. Since heart development in vivo requires instructive cues from exogenous sources like signaling from endoderm and mechanical forces of heart beat and growth, we aimed to leverage single-cell transcriptomic data to identify critical signaling or mechanical strategies for differentiating hPSCs to more accurately understand the identity of and control derivation of cardiac fates. We identify the non-DNA binding homeodomain protein HOPX, a key regulator of heart development (Jain et al., 2015) and hypertrophy (Chen et al., 2002; Kook et al., 2003; Shin et al., 2002) as dysregulated during differentiation and a potential cause for the immature state of hPSC-derived cardiomyocytes in vitro. Taken together, these data provide a unique resource for the field and identify a previously unappreciated strategy for enhancing differentiation of hPSC-derived cardiomyocytes in vitro for applications in cardiovascular biology.
RESULTS

Single-Cell RNA Sequencing Analysis of CardiacDirected Differentiation
To gain insights into the genetic regulation of cardiovascular development, we performed single-cell transcriptional profiling of human induced pluripotent stem cells (iPSCs) navigating from pluripotency through stage-specific transitions in cardiac differentiation ( Figure 1A ). Small-molecule Wnt modulation was used as an efficient method to differentiate pluripotent cells toward the cardiac lineage (Burridge et al., 2014; Lian et al., 2012) . WTC CRISPRi GCaMP human induced pluripotent stem cells (hiPSCs) (Mandegar et al., 2016) were chosen as the parental cell line for this study. These cells are genetically engineered with a doxycycline-inducible nuclease-dead Cas9 fused to a Kr€ uppel associated box (KRAB) repression domain. The versatility of this line provides a means to use this single cell RNA (scRNA)-seq data as a reference point for future studies aiming to assess the transcriptional basis of cardiac differentiation at the single-cell level. We captured cells at time points corresponding to stage-specific transitions in cell state including pluripotency (day 0), germ layer specification (day 2), and progressing through progenitor (day 5), committed (day 15), and definitive (day 30) cardiac cell states. A total of 44,020 cells were captured of which 43,168 cells were retained after quality control analysis. In total, we captured expression of 17,718 genes. Dimensionality reduction approaches were used to visualize all 43,168 cells in low-dimensional space (Figure 1B) , in which each cell's coordinates were estimated so that they preserve the expression similarity in t-SNE plots (left), and differentiation pseudotime in diffusion plots (right).
We generated a time-course gene expression profile using a wide range of known cardiac developmental genes by measuring expression among all cells to reveal the temporally restricted expression dynamics of stage-specific genes reflecting cardiac fate choices ( Figure 1C ). To confirm that the differentiation follows known developmental trajectories, we used dimensionality reduction methods (Coifman et al., 2005; Moignard et al., 2015) ( Figure 1D ) and unsupervised clustering (Clustering at Optimal REsolution [CORE] ) ( Figure 1E ) to analyze the expression of known genes. Overall, these data show that small-molecule-mediated cardiac-directed differentiation generates distinct populations of cells displaying expected temporal-specific transcriptional profiles. Our parallel computational genomics study ) presents a web interface (http://computationalgenomics. com.au/shiny/hipsc2cm/), provided as complementary resources for this study.
Phenotypic Diversity and Lineage Heterogeneity during Differentiation
With recent developments in high-resolution transcriptomic mapping of mouse in vivo development of the cardiovascular system (DeLaughter et al., 2016; Li et al., 2016) , we set out to map single-cell heterogeneity of human in-vitro-derived subpopulations against in vivo cell subpopulations. Using previously published approaches, laser microdissection was used to capture spatiotemporal transcriptional data from germ layer cells of mid-gastrula stage (E7.0) embryos , with an expanded analysis to include early-(E6.5) and late-gastrulation (E7.5) mouse embryos (unpublished data) ( Figure S1 ). To determine phenotypic identities based on gene expression networks governing each human in-vitro-derived subpopulation during differentiation, we visualized the spatiotemporal patterns of gene expression in the gastrulating mouse embryo including: EOMES (pan-mesendoderm), MESP1 and MIXL1 (mesoderm), SOX17 and FOXA2 (endoderm), and NKX2-5 (cardiac lineage transcription factor) (Figures 2A and S2) .
We subsequently dissected the transcriptional phenotype of subpopulations identified during human cardiac-directed differentiation. From pluripotency ( Figures S3A and S3B ), cells navigate through germ layer specification (day 2), comprising three transcriptionally distinct subpopulations expressing the pan-mesendoderm gene, EOMES ( Figures 2B, 2C , and S2A) with subpopulations expressing genes involved in mesoderm (D2:S2), mesendoderm (D2:S3), and definitive endoderm (D2:S1) ( Figures 2B, 2C , S2D, S3C, and S3D). Gene ontology (GO) analysis of differentially expressed genes between subpopulations indicated that only D2:S2 (34% of cells at day 2) showed significant enrichment for cardiogenic gene networks ( Figure 2D ; Table S1 ). At the progenitor stage (day 5), we identified cardiac precursors (D5:S1 and D5:S3) ( Figures 2E, 2G , and S3E), a persistent population of definitive endoderm (D5:S2) ( Figures 2E, 2F , and S3E), and a small population of endothelial cells in D5:S3 ( Figures 2E-2G ). Day 15 and day 30 cells comprised two subpopulations ( Figures 2H-2M , S3F, and S3G). NKX2-5, MYH6, TTN, and other cardiac structural and regulatory genes were identified in S2 ( Figures 2H-2M , S3F, and S3G). In contrast, S1 was primarily characterized by GO enrichment for genes associated with extracellular matrix deposition, motility, and cell adhesion ( Figures 2J and 2M ), which was supported by identification of a significant number of fibroblast-like cells marked by THY1 (CD90) (Figures 2I and 2L) . The co-existence of a non-contractile cell population, which is characterized as non-myocytes, is common in directed cardiac differentiation (Dubois et al., 2011) . Taken together, these data show iPSC differentiation into committed (day 15) and definitive (day 30) cardiomyocytes (S2) and noncontractile cells (S1) ( Figure 2N) . To assess the level of maturity derived from this protocol relative to in vivo human development, we compared day 30 clusters against ENCODE RNAsequencing (RNA-seq) data from fetal and adult hearts ( Figure 2O ). Using genes that reflect either early fetal (TNNI1, MYH6) versus late stages of heart development (MYH7, TNNI3, MYL2), the most differentiated in-vitro-derived cardiac population (D30:S2) remains more developmentally immature than even first trimester human hearts.
Lineage Predictions Based on Regulatory Gene Networks Governing Differentiation
We next sought to understand the lineage trajectories and gene regulatory networks governing diversification of cell fates. We implemented a probabilistic method for constructing regulatory Figure 1 . Single-Cell Analysis of Cardiac-Directed Differentiation (A) Schematic of protocol for small-molecule-directed differentiation from pluripotency into the cardiac lineage. hPSC, human pluripotent stem cell; GLS, germ layer specification; PC, progenitor cell; cCD, committed cardiac derivative; dCD, definitive cardiac derivative. (B) Single cell (n = 43,168 in total) analysis of cardiac differentiation beginning at pluripotency (day 0) and transitioning through mesoderm (day 2) into progenitor (day 5), committed (day 15), and definitive (day 30) cardiac derivatives. Data are presented using t-SNE plot, pseudospacing cells by the nonlinear transformation of similarity in gene expression to preserve the local and global distance of cells in multidimensional space when embedded into two dimensional t-SNE space (left), and diffusion plot, pseudospacing cells in a trajectory based on diffusion distance (transition probability) between two cells (right). (C) Mean gene expression across all cells at individual time points showing proper temporal expression of stage-specific genes governing differentiation into the cardiac lineage. Shown are pluripotency genes (DNMT3B, POU5F1, NANOG), mesendoderm genes (EOMES, MIXL1, T, MESP1), and genes governing cardiomyocyte differentiation including signaling regulators (TMEM88), transcription factors (ISL1, HAND1, TBX5, GATA4) , calcium handling genes (ATP2A2, PLN), and sarcomere genes (TNNI1, MYH6, MYH7, MYL7) . Data are represented as mean ± SEM. (D) Diffusion plots showing pseudospacing at single-cell resolution for gene expression of stage-specific genes during differentiation based on known genetic regulators of cardiac fate specification including POU5F1 (day 0), EOMES (day 2), TMEM88 (day 5), TNNI1 (day 15), and TTN (day 30). Cells are colored in a binary manner. If the cell expresses the gene, it is colored according to the day of isolation (0, 2, 5, 15, or 30) . Non-expressing cells are shaded gray. (E) Representation of unsupervised clustering analysis using t-SNE plots to show single-cell level expression of stage-specific gene expression at each day of differentiation based on known genetic regulators of cardiac fate specification including POU5F1, EOMES, ISL1, TNNI1, and MYL7. If the cell expresses the gene, it is colored according to subpopulation 1-4 in which the cell is associated. Non-expressing cells are shaded gray. Above each t-SNE plot, the percentage of cells expressing the gene in each subpopulation is shown together with the expression density plot and the reference t-SNE plot. UMI, unique molecular identifier.
Figure 2. Subpopulation Identification and Characterization
(A) Corn plots showing spatial domains of EOMES, MESP1, SOX17, and NKX2-5 expression in the mesoderm and endoderm of E6.5, E7.0, and E7.5 mouse embryos during gastrulation (unpublished RNA-seq data for E6.5 and E7.5 mouse embryos and published data for E7.0 mouse embryos ). Positions of the cell populations (''kernels'' in the 2D plot of RNA-seq data) in the germ layers: the proximal-distal location in descending numerical order (1 = most distal site) and in the transverse plane of the mesoderm and endoderm-anterior half (EA) and posterior half (EP) of the endoderm, anterior half (MA) and posterior half (MP) of the mesoderm, posterior epiblast (P) containing the primitive streak, and expression from anterior (A) to posterior (P) primitive streak (only for EOMES).
(legend continued on next page) networks from single-cell time series expression data (scdiff: cell differentiation analysis using time-series single-cell RNA-seq data) (Ding et al., 2018) . The algorithm utilizes transcription factor (TF)-gene databases to model gene regulation relationships based on the directional changes in expression of TFs and target genes at parental and descendant states.
The algorithm identified three distinct lineages from pluripotency comprising 10 nodes (Table S2 ; Figure 3A ). Since this algorithm reassigns cells based on regulatory networks, we analyzed the distribution of cell subpopulations based on our CORE cluster classifications as outlined in Figure 2 to establish population identities linking predicted lineages ( Figures 3A, 3B, 3B , and S4A). We leveraged the regulatory network predictions to identify key transcription factors and target genes underlying progressive fate changes across all 10 nodes ( Figure 3C ; Table S2 ).
These data reinforce established mechanisms of cardiac lineage specification. In particular, we found evidence for downregulation of Wnt/b-catenin signaling (LEF1) between N4 and N6, which is required to transition from mesoderm into the cardiac progenitor cell (Palpant et al., 2013; Ueno et al., 2007) . From the progenitor node N6 into contractile cardiomyocytes N7:N9, the data show proper downregulation of progenitor transcription factors such as YY1 and upregulation of TFs known to control cardiomyocyte differentiation such as NKX2-5 ( Figure 3C ).
We next sought to understand gene networks underlying specification of non-contractile cardiac derivatives N8:N10, a population currently not well defined although widely used for tissue engineering applications (Thavandiran et al., 2013) . The predicted network underlying this transition showed significant downregulation of cardiac TFs NKX2-5 and MAZ and upregulation of Pre-B cell leukemia transcription homeobox (PBX1: p = 1.1e -16 , mean DE target fold change = 2.72), a transcriptional regulator that activates a network of genes associated with cardiac outflow tract (OFT) morphogenesis (Arrington et al., 2012) ( Figure 3C ).
We compared expression of a panel of cardiomyocyte, early developmental vascular endothelial, and OFT development genes across all subpopulations comprising transitions from day 5 to 30 ( Figure 3D ). While early developmental vascular EC differentiation genes (TAL1, CDH5) were expressed in D5:S3, these genes were not expressed in D15 or D30. Furthermore, while D15 and D30:S2 cells expressed cardiac sarcomere genes and transcription factors (IRX4 and HCN4), S1 cells uniquely expressed an extensive network of genes associated with OFT development including PITX2, TBX18, HOXA1-3, FGF10, GJA1, and KDR ( Figure 3D ). To determine the strength of this association, we performed GO analysis of differentially expressed genes between D30:S1 (N10) and D30:S2 (N9) cells. These data show a significant enrichment for gene networks related Table S1 .
to vascular development (p = 1.1e -11 ) and blood vessel morphogenesis (p = 4.7e -9 ) exclusively within node 10 D30:S1 cells. This finding is supported by single-cell visualization showing enrichment of OFT-associated genes expressed in S1 versus S2 including THY1 (59% D30:S1 versus 2% D30:S2), BMP4 (70% D30:S1 versus 6% D30:S2), and PITX2 (73% D30:S1 versus 17% D30:S2) ( Figures 3E and 3F ).
To link this observation to in vivo cell types, we used single-cell RNA-seq data of in vivo heart development to identify the top most differentially expressed genes between OFT and left ventricle (LV). These data show expression of BMP4, RSPO3, TNC, and COL1A2 in D30:S1 and in vivo OFT derivatives and MYL2 and HOPX upregulated in cardiomyocytes and expression of these genes similarly differentially expressed in D30 S1 versus S2 subpopulations ( Figure 3G ). To assess cell-type-specific transcriptional signatures, we identified differentially expressed genes between D30 S1 versus S2 and performed a Spearman rank correlation analysis against expression profiles of in vivo fluorescence-activated cell sorted (FACS) or single-cell-derived cardiac subtypes . These data show that D30:S1 has a significantly stronger correlation to OFT cells (Spearman's r = 0.442) than to fibroblasts (Spearman's r = 0.219), endothelium (Spearman's r = 0.175), or myocardium (Spearman's r = 0.243) (p < 2.2 3 10 À16 for all pairwise comparisons) ( Figure 3H ). Collectively, these data indicate that directed differentiation generates See also Figure S4 and Table S2. definitive cell populations comprising contractile cardiomyocytes and a non-contractile cell type whose transcriptional signature correlates with cardiac OFT cells. Due to the complex cellular origins of cardiac OFT and the diversity of non-contractile cell types of the heart in vivo, further studies are required to determine the specific identity and biology of these cells and their application in disease modeling and tissue engineering.
HOPX Is Dysregulated during In-Vitro-Directed Differentiation from hPSCs We next aimed to identify dysregulated gene networks with the objective of determining different mechanisms for modeling in vitro differentiation to more accurately reflect in vivo heart development. Focusing on core regulatory genes governing transcriptional networks in heart development, we analyzed 52 transcription factors and epigenetic regulators known to govern diversification of mesoderm and endoderm lineages (Table S3) . HOPX, a non-DNA binding homeodomain protein identified in this analysis, has previously been shown to be one of the earliest, specific markers of cardiomyocyte development (Jain et al., 2015) and governs cardiac fate by regulating cardiac gene networks through interactions with transcription factors, epigenetic regulators, and signaling molecules (Chen et al., 2002; Jain et al., 2015) . We have also recently shown that HOPX functionally regulates blood formation from hemogenic endothelium . Consistent with mouse heart development, analysis of human fetal development at each trimester indicate a robust activation of HOPX during heart development in vivo ( Figure S5A ). Previous studies have shown HOPX is expressed during cardiomyocyte specification at the progenitor stage of mouse development in vivo (Jain et al., 2015) , whereas we detected HOPX only in endothelium (D5:C3) and not in cardiac precursor cells (D5:C1) at an equivalent time point (day 5) of in vitro differentiation ( Figures 4A and 4B ). Second, in contrast to previous studies in vivo where HOPX lineage traces almost all cardiomyocytes of the heart (Jain et al., 2015) , HOPX is detected in only 16% of D30:S2 cardiomyocytes ( Figures 4B-4D ). To rule out stochastic expression in cardiomyocytes due to low sequencing read depth resulting in dropout, we analyzed expression of genes known to regulate cardiac lineage specification and differentiation ( Figures  4C and 4D ). While HOPX is rarely detected, its expression level is equivalent to that of other cardiac TFs that are detected in a high percentage of D30:S2 cardiomyocytes (HAND1: 67%, HAND2: 64%, GATA4: 67%, NKX2-5: 86% versus HOPX: 16%) ( Figures  4B-4D) .
We utilized expression data derived from in vivo development to evaluate HOPX expression during cardiovascular development. Assessment of gene expression during mouse gastrulation in vivo shows HOPX expression as early as E6.5 in the proximal portion of the nascent primitive streak (P) (Figures 4E, S5B, and S5C) similar to the expression pattern of MESP1 (Figures S5D and S5E) . From E7.0 to E7.5, HOPX is increasingly expressed throughout the developing endoderm. By E7.5, HOPX displays residual expression in the remaining distal primitive streak, endoderm (EA to EP), and the anterior mesoderm (MA) in coordination with other cardiogenic genes including NKX2-5 and MESP1 (Figures 4E and 2A) . We analyzed HOPX expression across diverse cell types contributing to heart development in vivo using single-cell transcriptomic analysis of the E9.5 mouse heart S4D ).
Chromatin and Expression Analysis of HOPX in Cardiac Lineage Specification
To determine the epigenetic basis for HOPX dysregulation during in vitro differentiation, we analyzed chromatin and transcriptional regulation at the HOPX locus (Palpant et al., 2017a ) ( Figure S5F ). Chromatin immunoprecipitation data for repressive chromatin (H3K27me3), actively transcribed chromatin (H3K4me3), and gene expression by RNA-seq show that in the context of cardiac-directed differentiation HOPX is epigenetically repressed on the basis of abundant H3K27me3 compared to H3K4me3 in day 5 cardiac precursor cells ( Figure S5F ). This is consistent with RNA-seq, quantitative real-time PCR, and analysis of HOPX activity in tdTomato knockin HOPX reporter cells showing that HOPX is expressed late during cardiac differentiation, well after sarcomere formation and weeks after the onset of spontaneously beating cells during cardiac-directed differentiation ( Figures  4B, S5F , and S6A-S6D). The highest level of HOPX expression was observed in cardiomyocyte cultures maintained for 1 year (Figures S5F and S5G) . Collectively, these data show a direct link between chromatin regulation of the HOPX locus and expression of HOPX in cardiac lineage specification in vitro.
HOPX Drives Cardiomyocyte Hypertrophy
To determine the functional role of HOPX, we established conditional HOPX overexpression hPSCs in which a nuclear localized HOPX is targeted to the AAVS1 locus ( Figure 5A ). Using western blot, quantitative real-time PCR, and immunostaining, we show that HOPX transcript and HOPX protein is overexpressed in a doxycycline-inducible manner and is nuclear localized ( Figures  5A-5C ). Morphometric analysis of dox-treated cardiomyocytes showed a significant increase in cell area under conditions of HOPX overexpression ( Figure 5D ) consistent with previous studies showing that forced Hopx expression in vivo causes cardiac hypertrophy (Chen et al., 2002; Kook et al., 2003; Shin et al., 2002) . We performed bulk RNA sequencing analysis on control versus HOPX OE cardiomyocytes to determine global transcriptomic changes (Figures 5E-5H; Table S5 ). Analysis of differentially expressed genes showed a significant enrichment of gene ontologies associated with signaling pathways (ERK1-2, IGF-1) and gene networks involved in cell growth and maturation (E) Corn plots showing the spatial domains of HOPX expression in the mesoderm and endoderm of E7.0 and E7.5 mouse embryos during gastrulation (unpublished RNA-seq data for E7.5 embryos and published data for E7.0 embryo ) ( Figure S1 ). (F) Single-cell expression analysis of E9.5 mouse heart cells showing Hopx expression relative to markers of cardiomyocytes (Myh7, Actn2) and endothelial cells (Cdh5, Pecam1) (scale bars are Log 2 (CPM)). Table S5 ).
The HOPX Locus Is Activated by Hypertrophic Stimulation Hypertrophic stimulation is modeled poorly in high-density monolayer cardiac-directed differentiation due to the absence of exogenous hypertrophic signals. On the basis that this discrepancy may, at least in part, explain the dysregulation of HOPX in vitro, we tested the reciprocal hypothesis that exogenous hypertrophic stimuli is sufficient to drive HOPX expression in vitro. We implemented an established approach for stimulating hypertrophy (Uesugi et al., 2014) in which high-density monolayer-derived cardiomyocytes are replated at low density at day 10 and analyzed at day 15 ( Figure 6A ). In keeping with a hypertrophic response, replating cardiomyocytes results in significantly increased cell area, anisotropy (Figures 6B and 6C) , and upregulation of genes governing cardiac hypertrophic growth including NPPB, MYOCD, EDN1, and IGF-1 ( Figure 6D ). Importantly, we found that replating cardiomyocytes resulted in a greater than 10-fold increase in HOPX expression ( Figure 6E ) in coordination with significant increases in expression of myofibrillar isoforms (MYH7, MYL2, TNNI3) and transcription factors (SRF) involved in cardiomyocyte maturation ( Figure 6F ). HOPX reporter human embryonic stem cells (hESCs) in which tdTomato is knocked into the translational start site of HOPX (Figure S6C ). These data show that HOPX is robustly activated uniformly in replated cardiomyocytes (Figure 6G) . We further show that treatment with Endothelin-1 (ET-1), a potent stimulus of cardiomyocyte hypertrophy, significantly increases HOPX expression albeit to a much lower level than replated cardiomyocytes ( Figure 6H ). Taken together, these results indicate that transcriptional activation of the HOPX locus is downstream of hypertrophic signaling.
Dissecting the Transcriptional Complexity of HOPX Regulation Underlying Cardiomyocyte Hypertrophy While genetic loss of HOPX did not impact specification of cardiomyocytes ( Figures S6E and S6F) , we set out to study the functional requirement and underlying complexity of the HOPX locus in cardiomyocyte hypertrophy. To this end, we utilized CRISPRi loss-of-function hPSCs to conditionally block HOPX expression at each of its two transcriptional start sites, which we term the proximal transcriptional start site (TSS) (g4) and distal TSS (g1) ( Figure 6I ). Multiple exon-spanning primers were designed to map transcriptional activity across the HOPX locus ( Figure 6I ). Cells were differentiated into the cardiac lineage ± dox and analyzed at day 15 of differentiation under standard high-density monolayer conditions versus replating. All HOPX transcripts were significantly increased during replating ( Figure 6J ; Table  S6 ). However, inhibition of the proximal TSS (g4) repressed expression from that locus (HOPX C) with no effect on transcriptional activity from the distal TSS (HOPX A) ( Figure 6J ). In contrast, inhibition of the distal HOPX TSS (g1) resulted in a global reduction of HOPX expression (HOPX A-E) ( Figure 6J ). This indicates that HOPX has functionally distinct TSSs with the distal TSS functioning as the primary target of regulatory factors driving expression of HOPX in the context of hypertrophic stimulation.
To determine the functional requirement of HOPX in hypertrophy, we analyzed hypertrophy-related genes ( Figure 6K ; Table  S6 ). Loss of HOPX function from the distal or proximal TSS did not impact expression of any hypertrophic genes tested including IGF-1 (Figure 6K ), the most highly upregulated hypertrophy gene in HOPX OE ( Figure 5I ). We next assessed a panel of cardiac genes associated with maturation. We found that maturation-related myofibrillar genetic isoforms (MYL2, MYH7, TNNI3) were significantly depleted when the distal HOPX TSS was inhibited (g1). In contrast, knockdown of the proximal TSS (g4) had small but significant effects on expression of MYL2 and MYH7 but a significant increase in expression of the early fetal MYH6 isoform relative to controls ( Figure 6L ; Table S6 ). Expression of selected key cardiac transcription factors was not impacted by HOPX loss of function with the exception of a significant increase in GATA4 with knockdown of the distal TSS (g1) ( Figure 6M ; Table S6 ). These data indicate that, while genetic networks underlying hypertrophy and early cardiomyocyte myofibrillar development are not dependent on HOPX, we found it plays a key role driving maturation at least in part through regulating expression of late-stage genetic isoforms of myofibrillogenesis with the distal TSS playing a more dominant role compared to the proximal TSS.
We next assessed the impact of HOPX loss of function on morphometric parameters of cardiomyocyte hypertrophy. Cell area was measured at two time points post replating and showed a progressive and significant increase in cell size indicative of cardiomyocyte hypertrophy in control cells and conditions blocking the proximal HOPX TSS (g4) ( Figure 6N ). However, blocking transcription of the distal HOPX TSS (g1) attenuated the hypertrophic growth ( Figure 6N ). Taken together, we have identified HOPX as a known key epigenetic regulator of cardiovascular development that is dysregulated during in-vitro-directed differentiation from hPSCs. Using genetic models, we show Figure S6 and Table S6. that HOPX is situated downstream of hypertrophic signaling pathways and is essential for downstream expression of cardiac myofibrillar genetic isoforms involved in cardiomyocyte growth and maturation ( Figure 6O ).
DISCUSSION
This study provides single-cell transcriptional analysis of human cardiac-directed in vitro differentiation. Identification and characterization of in-vitro-derived cell types are supported by spatiotemporal gene expression of the gastrulating mouse embryo and single-cell analysis of in vivo heart development. Cardiac-directed differentiation protocols using small molecules to modulate Wnt signaling have emerged in recent years as a simple, cost-effective, and reliable method to generate high-purity cardiac derivatives from hPSCs. In light of diverse applications of this protocol in cardiovascular discovery and translational research, the current study provides genome-wide analysis of 43,168 cell transcriptomes undergoing stage-specific changes in gene expression during cardiac differentiation as a resource with which to dissect cell subpopulations at the molecular level. Analysis of subpopulations during early stages of differentiation indicate a surprising contribution of mesendoderm and definitive endoderm coordinately specified with cardiac fates through the progenitor stage of differentiation. In particular, a minority of cells (34%) comprise MESP1 + cardiogenic mesoderm at day 2 that are predicted to ultimately give rise to all cardiac derivatives at day 30. The interaction between endoderm and mesoderm in governing lineage specification in vivo is well known, and these data suggest that a critical functional role of induction cues provided by directed differentiation protocols is to establish the necessary population stoichiometry of transiently sustained endoderm required to support mesoderm in the derivation of high-purity cardiac fates in vitro. We evaluated lineage trajectories from single-cell data by implementing a lineage prediction algorithm, scdiff, specifically designed for learning regulatory networks controlling differentiation from single-cell time series data. These data revealed insights into the bifurcation of cardiac precursor cells at day 5 of differentiation into NKX2-5 + /MYL2 + ventricular cardiomyocytes and a population of non-contractile cells with transcriptional networks similar to NKX2-5 -/PITX2 + cardiac OFT cells. While previous studies have routinely described a non-contractile THY1 + (CD90 + ) fibroblast-like cells for tissue engineering applications (Thavandiran et al., 2013) , this population remains poorly studied. We provide single-cell level transcriptome-wide evidence directly linked to in vivo cell cardiac types that noncontractile THY1 + cells are similar to cardiac OFT derivatives. Of importance, congenital heart disease (CHD) is among the most common forms of congenital defects and OFT anomalies account for roughly 30% of CHD incidences (Thom et al., 2006) . Given the complexity of OFT differentiation and morphogenesis that involves cell types form diverse origins, future work will require analysis of this population as it pertains to the cellular origins of OFT, septum, and other non-contractile cell types of the heart.
It is well established that in vitro cardiac differentiation does not generate cardiomyocytes with the transcriptional profile, cellular diversity, morphometry, or functional maturity of adult in-vivo-derived cardiomyocytes (Yang et al., 2014) . Among a panel of candidate regulatory genes studied, we focused on HOPX as a key developmental regulator of cardiac myoblasts early in heart development in vivo (Jain et al., 2015) that is rarely expressed in in-vitro-derived cardiomyocytes. We tested the hypothesis that the dysregulation of HOPX was the consequence of deficiencies in directed differentiation accurately mimicking the signaling and mechanical stimuli of the developing heart. To address this, we aimed to understand the basis for activating HOPX and its downstream gene networks in vitro by identifying the upstream cues required for its expression. Utilizing gain-and loss-of-function genetic models, we provide a comprehensive profiling of the complex transcriptional landscape of HOPX as a central regulator of the cardiomyocyte response to hypertrophy. Our data show that the distal TSS is the primary hypertrophy responsive element and regulation of HOPX through this TSS functionally governs gene networks and cellular morphometric growth associated with cardiomyocyte hypertrophy and maturation.
Taken together, this study provides insights into the complexity of cell populations represented in stage-specific transitions from pluripotency and establish a unique reference point for dissecting gene networks involved in human cardiac development and disease. Promoting adult-like phenotypes from in-vitro-differentiated cell types is essential for the realization of the translational applications of hPSCs in disease modeling and therapy. This study provides evidence that HOPX expression is a key transcriptional regulator near absent during high-density cardiac-directed differentiation in vitro, requiring hypertrophic stimulation to accurately direct HOPX and its downstream networks underlying the transcriptional and functional maturity of hPSC-derived cardiomyocytes.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Generation and Maintenance of Human ESC/iPSC Lines All human pluripotent stem cell studies were carried out in accordance with consent from the University of Queensland's Institutional Human Research Ethics approval (HREC#: 2015001434). The RUES2-td-Tomato reporter (karyotype: 46, XX; RRID CVCL_VM29) and RUES2 HOPX KO (karyotype; 46, XX; RRID CVCL_VM28) human ES cell lines were generated as previously described . WTC CRISPRi GCaMP hiPSCs (Karyotype: 46, XY; RRID CVCL_VM38), generously provided by M. Mandegar and B. Conklin (UCSF, Gladstone Institute), was generated using a previously described protocol (Mandegar et al., 2016) . WTC CRISPRi HOPX g4 (XY; RRID CVCL_VQ28), WTC CRISPRi HOPX g1 (XY; RRID CVCL_VQ27), WTC HOPX-NLS-eGFP (XY; RRID CVCL_VM46), and WTC NLS-eGFP (XY; RRID CVCL_VM47) hiPSCs were generated in this study (see below). All cells were maintained as previously described (Palpant et al., 2017a) . Briefly, cells were maintained in mTeSR media with supplement (Stem Cell Technologies, Cat.#05850) at 37 C with 5% CO 2 . All hESCs, WTC HOPX-NLS-eGFP, and WTC NLS-eGFP lines were maintained on matrigel growth factor reduced basement membrane matrix (Corning, Cat.#356231), while WTC CRISPRi, WTC CRISPRi HOPX g4, and WTC CRISPRi HOPX g4 hiPSC lines were maintained on Vitronectin XF (Stem Cell Technologies, Cat.#07180) coated plates. Despite no overt abnormalities, WTC CRISPRi cells and their derivatives are non-wild-type and comprise the sole cell type analyzed by scRNA-seq. Further verification of these findings using different cell lines is suggested.
WTC CRISPRi HOPX g4 and g1 hiPSCs HOPX-targeted guide RNAs (gRNA) were designed to target sequences near the human HOPX distal and proximal transcription start sites, were cloned into the pQM-u6g-CNKB doxycycline-inducible construct and transfected into WTC CRISPRi GCaMP hiPSCs using GeneJuice Transfection Reagent (Merck, Cat.#70967). Stable clones were selected using successive rounds of re-plating with blasticidine at 10mg/ml (Sigma, Cat.#15205). Populations were tested for knockdown efficiency by qPCR following doxycycline addition at 1 mg/ml (Sigma, Cat.#D9891) continuously from day 0 of cardiac-directed differentiation.
WTC HOPX-NLS-eGFP and WTC NLS-eGFP hiPSCs
We cloned the human HOPX ORF fused to a nuclear localization sequence (CCAAAGAAGAAGCGGAAGGTC) and GFP into the AAVS1 targeting plasmid (pZDonor, Sigma). 1x10 6 WT WTC hiPSCs were transfected with 0.5 mg AAVS1-TALEN, 0.5 mg AAVS1-TALEN and 4 mg of HOPX-NLS-eGFP or 4 mg of NLS-eGFP to generate the HOPX line and the negative control line, respectively, using Amaxa Human stem cell Kit #2 (Lonza, Cat.#VVPH-5022). The cells were then plated with 5mM ROCK inhibitor onto Matrigel-coated plates in mTeSR. Two days following the nucleofection, the cells were selected for puromycin resistance using puromycin at 0.5 mg/ml for 48 hours.
METHOD DETAILS
Cell Culture All human pluripotent stem cell studies were carried out in accordance with consent from the University of Queensland's Institutional Human Research Ethics approval (HREC#: 2015001434). hESCs and hiPSCs were maintained in mTeSR media (Stem Cell Technologies, Cat.#05850). Unless otherwise specified, cardiomyocyte directed differentiation using a monolayer platform was performed with a modified protocol based on previous reports (Burridge et al., 2014; Lian et al., 2012) . On day À1 of differentiation, hPSCs were dissociated using 0.5% EDTA, plated into vitronectin or matrigel coated plates at a density of 1.8 3 10 5 cells/cm 2 , and cultured overnight in mTeSR media. Differentiation was induced on day 0 by first washing with PBS, then changing the culture media to RPMI (ThermoFisher, Cat.#11875119) containing 3mM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500mg/mL BSA (Sigma Aldrich, Cat.#A9418), and 213mg/mL ascorbic acid (Sigma Aldrich, Cat.#A8960). After 3 days of culture, the media was replaced with RPMI containing 500mg/mL BSA, 213mg/mL ascorbic acid, and 1mM Xav-939 (Stem Cell Technologies, Cat.#72674). On day 5, the media was exchanged for RPMI containing 500mg/mL BSA, and 213mg/mL ascorbic acid without supplemental cytokines. From day 7 onward, the cultures were fed every 2 days with RPMI plus 1x B27 supplement plus insulin (Life Technologies Australia, Cat.#17504001). For endothelin-1 assays, cells were treated with 300nM ET-1 (Sigma-Aldrich, Cat.#E7764) from day 9-15 of directed differentiation. For HOPX overexpression studies (Figure 5) , the following protocol was utilized: A monolayer-based directed differentiation protocol was followed to generate hiPSCCMs, as described previously (Palpant et al., 2017a) . On day 15 hiPSC-CMs were enriched by lactate selection (Tohyama et al., 2013) .
Quantitative real-time PCR
For quantitative real-time PCR, total RNA was isolated using the RNeasy Mini kit (QIAGEN, Cat.#74106). First-strand cDNA synthesis was generated using the Superscript III First Strand Synthesis System (ThermoFisher, Cat.#18080051). Quantitative real-time PCR was performed using SYBR Green PCR Master Mix (ThermoFisher, Cat.#4312704) on a ViiA 7 Real-Time PCR System (Applied Biosystems). The copy number for each transcript is expressed relative to that of housekeeping gene HPRT1. Quantification of cardiac hypertrophy gene expression was performed using Cardiac Hypertrophy H384 qPCR panels (BioRad, Cat.#10025144) with SYBR Green PCR Master Mix. Samples were run in biological triplicate. The copy number for each transcript is expressed relative to that of housekeeping gene HPRT1. FC was calculated on a gene by gene basis as gene expression divided by control gene expression. , and incubated overnight with primary antibody in 1% NGS, followed by secondary antibody staining in NGS. Measurements of CM area were performed using ImageJ software. Analysis was done on a Leica TCS-SPE Confocal microscope using a 40x or 63x objective and Leica Software. Primary antibodies used were: aActinin 1:250 (Clone EA-53; Sigma-Aldrich Cat# A7811, RRID:AB_476766), Titin 1:300 TTN-9 (cTerm) anti-rabbit (MyoMedix, Cat# TTN-9, RRID:AB_2734750), GFP 1:300 anti-rabbit (ThermoFisher, Cat# A-11122, RRID:AB_221569). Secondary antibodies and other reagents used were: DAPI at a concentration of 0.02 mg/mL, phalloidin alexa fluor 568 1:250 (ThermoFisher, Cat#A12380), goat anti-mouse alexa fluor 488 (ThermoFisher, Cat# A-11001, RRID:AB_2534069) or goat anti-rabbit alexa fluor 647-conjugated (ThermoFisher, Cat# A-21244, RRID:AB_2535812) secondary antibodies at 1:500.
Flow Cytometry
Cells were fixed with 4% paraformaldehyde (Sigma, Cat.#158127) and permeabilized in 0.75% saponin (Sigma, Cat.#S7900). Cells were labeled for flow cytometry using cardiac troponin T (ThermoFisher, Cat# MA5-12960, RRID:AB_11000742) or APLNR (R&D, Cat# FAB856A, RRID:AB_2044604) and corresponding isotype control. Cells were analyzed using a BD FACSCANTO II (Becton Dickinson, San Jose, CA) with FACSDiva software (BD Biosciences). Data analysis was performed using FlowJo (Tree Star, Ashland, Oregon).
Single Cell Isolation
For each differentiated day 0, 2, 5, 15, and 30 time point, differentiated cells were dissociated with 0.5% EDTA + 0.25% Trypsin (ThermoFisher, Cat.#15400054) and neutralized with fetal bovine serum (GE Healthcare Life Sciences, Cat.#SH30084.03) and DMEM/F12 media (Sigma, Cat.#11320033) (1:1 ratio). For each time point, 2 pooled samples were collected, each pool comprised approximately 12 independent differentiation samples. Cells were centrifuged at 1200 rpm for 4 minutes and resuspended in Dulbecco's PBS (GIBCO; Cat.#14190) with 0.04% bovine serum albumin (Sigma Aldrich, Cat.#B6917) and immediately transported for scRNA-Seq processing. Viable cells were sorted using a Propidium Iodide stain and retained on ice in Dulbecco's PBS + 0.04% bovine serum albumin. A Countess automated counter (Invitrogen) was used to check final cell viability using Trypan Blue exclusion. were loaded into Single Cell 3 0 chips (10X Genomics) at a concentration optimized to capture approximately 5,000 cells in individual 1-cell droplets. Single cell libraries were sequenced using an Illumina NextSeq 500 instrument as previously described .
Bioinformatics Processing
Bioinformatics mapping of reads to original transcripts and cells was by cellranger pipeline v1.3.1 by 10X Genomics (http://www. 10xgenomics.com/). We used cellranger mkfastq to prepare demultiplexed raw base call files into library-specific FASTQ files, with the following parameters-use-bases-mask = ''Y26n*,I8n*,n*,Y98n*''-ignore-dual-index. The FASTQ files were separately mapped to the GRC38p7 human reference genome using the STAR21 (Dobin et al., 2013) as a part of the cellranger pipeline. Gene expression counts were done using cellranger count based on Gencode v25 annotation and cell identifiers and Unique Molecular Identifiers (UMI) were filtered and corrected with default setting. Raw cellranger count outputs for two biological replicates in each time point were aggregated and normalized by a subsampling procedure using cellranger aggr (Zheng et al., 2017) . After sample-to-sample normalization, we filtered outlier genes and cells which were outside the range of 3x median absolute deviation (MAD) of the number of cells with the detected genes, ribosomal reads, mitochondrial reads, and total read mapped to cells to remove noise due to sequencing depth or cell conditions. Further, cells with above 50% ribosomal reads, or above 20% mitochondrial reads, and genes detected in fewer than 0.1% total cells were also removed. Post filtering, cell-to-cell normalization was done by scran using pooling sizes of 40, 60, 80 and 100 without using a quickClustering option (Lun et al., 2016) . Data dimensionality reduction by PCA and t-SNE are previously described in Nguyen et al. and as is implemented in the R ascend package (Senabouth et al., 2017) . Briefly, PCA using the R prcomp function was based on the top 1500 most variable genes. We selected the top 10 principal components (PCs) that explained most variance, as confirmed by Scree plot using fa.parallel package. For visualization, nonlinear dimensionality reduction using Rtsne v0.13 package for the top 10 PCs was performed to produce coordinates for cells in 2 dimensional or 3 dimensional tSNE space.
Clustering algorithm was described in 2018) and is implemented in the ascend (Senabouth et al., 2017) as well as the scGPS R packages. Briefly, for each aggregated dataset in each time point, we calculated the top 10 PCs as the input for the CORE clustering algorithm. We first built a high-resolution clustering tree structure based on cell-to-cell Euclidean distance and Ward's minimum variance with an agglomerative hierarchical clustering (HAC). The branches in the dendrogram tree were dynamically grouped into clusters by a cuttreeDynamic method in the dynamicTreeCut v1.63 package. We performed dynamic clustering 40 times for different height cutoffs spanning 99% of the joining height of the initial dendrogram distance tree. The resulting clusters from the 40 runs were compared by using adjusted Rand indexes (ARI) to find a stable clustering point . The optimal clustering point meets two criteria, including robust to changing parameters and less different from a reference with the highest number of clusters. We validated the CORE clustering results using multiple dimensionality reduction and clustering methods, including PCA, tSNE, Multidimentional Scaling (MDS) and Clustering through Imputation and Dimensionality Reduction (CIDR) (Lin et al., 2017) .
The processed data post filtering, normalization, and clustering was used as the input for differential expression analysis. We performed DESeq (Anders and Huber, 2010) analysis to find differentially expressed genes between cells in one subpopulation compared to all remaining cells in other subpopulations at a given time-point. We observed that when comparing subpopulations with different number of cells, DESeq was faster and produced more stable performance than DESeq2, consistent to the report by Dal Molin et al. (Dal Molin et al., 2017) . Briefly, one pseudocount was added to scran cell-to-cell normalized counts, which were then rounded to integer values before estimating dispersion (with the fitType option set to local) and running negative binomical test function in DESeq. After significant testing, we performed fold change adjustments to subtract mean expression by one, which allowed more accurate estimation of fold changes for lowly expressed genes. Bonferroni correction as applied to account for multiple testing error.
Furthermore, for reproducibility and broader usability of the valuable data resource, we have submitted all data to Array Express and created a web database resource with interactive data mining tools for users to explore the entire dataset without requirement for programming.
Initial Clustering of Single Cells scdiff starts by clustering the cells in each of the time points measured. While the original scdiff method used spectral clustering, this method was unable to scale for the large number of cells profiled in this study. We have thus revised scdiff for this study by changing the original clustering methods to a more efficient method. Specifically, we used PCA with 10 dimensions followed by K-means for the initial clustering which led to faster runtime while not greatly affecting performance. To determine the initial number of clusters (k) for each time point we combine 3 widely used clustering quality assessment scores: the Silhouette Score (Rousseeuw, 1987) , DavisBouldin index (Davies and Bouldin, 1979) and AIC (Akaike, 1998) (Akaike information criterion) . We used a bootstrapping strategy to combine these. We first selected a random subset of 90% of the genes. Next, we calculate the Silhouette score, Davis Bouldin score and AIC scores for different k values between 2 and 20 for each time point. We compute a combined score for each of these k values based on the subset of genes selected and repeat this process 100 times (each time with a new random gene subset). We select the optimal k by summing up the scores for each of the possible k values across the 100 repeats.
Initial Model Construction
Initial clustering is based on the time point associated with each cell. However, several recent studies indicate that cells may be unsynchronized with respect to their state even if they are collected at the same time point (Trapnell et al., 2014) . Thus, some of the clusters at a specific time point may represent states that are either earlier or later than other clusters in the same time. To address this we next use a correlation-based method to reassign clusters to time points. Once we determined the set of clusters associated with each level (time point), we connect clusters in each level to the most similar cluster (in terms of correlation) at the level directly above it (its parent cluster). This leads to a directed graph with potentially multiple roots (initial set of clusters for the first time points) which structurally represents the initial differentiation model. Predicting TFs Regulating Differentiation Pathways An important aspect of scdiff is the ability to both reconstruct and analyze the differentiation pathways based on the set of TFs that regulate various state transitions. We used bulk TF-gene interaction data from (Ernst et al., 2007; Schulz et al., 2012) for this analysis. Following the initial model construction, we first identify a set of differentially expressed (DE) genes for each cluster (state) in our model. Using this set, we identify TFs that are enriched for DE targets based on the hyper-geometric distribution. Next, we check which of the candidate TFs is expressed in the parent node of the state. TFs that are both significantly enriched and expressed are used in the to define a logistic regression function which modifies the likelihood of assigning cells to the different clusters in the model Thus, cell assignment is based on both, expression similarity to other cells in the state and the expression of targets of TFs predicted to regulate this state. Iterative Assignment of Cells to States Given initial assignments of cells and TFs to states, we can compute the MLE of the transition and emission noise variance. We next iterate between two steps. The first uses the parameters learned to reassign cells and TFs to states and the second uses the assigned cells and TFs to re-learn model parameters. During the iterative process some states may become empty and if this happens they are removed from the model. The process stops when it converges (no more cells are re-assigned) and the resulting model is returned.
scdiff Parameters Used in This Study scdiff was run with the following parameters: -k auto -l 1 -s 1 -d 1. For the scdiff input expression matrix, we performed, as described above, a thorough quality check to remove outlier genes and cells (outside 3 x median absolute deviation range) based on mitochondrial, ribosomal genes, library sizes, and number of detected cells. This data processing pipeline was implemented in the ascend pipeline (Senabouth et al., 2017) . The preprocessed expression data matrix was then normalized at two levels (as described above): by batches (using the cellranger aggr function), and then by cells (using the deconvolution method in the scran package). The filtered and normalized matrix was then used for scdiff.
QUANTIFICATION AND STATISTICAL ANALYSIS
Unless otherwise noted, all data are represented as mean ± standard error of mean (SEM). Indicated sample sizes (n) represent biological replicates including independent cell culture replicates and individual tissue samples. No methods were used to determine whether data met assumptions of the statistical approach or not. Due to the nature of the experiments, randomization was not performed and the investigators were not blinded. Statistical significance was determined in GraphPad Prism 7 software by using Student's t test (unpaired, two-tailed) or ordinary one-way ANOVA unless otherwise noted. Results were considered to be significant at p < 0.05(*). Statistical parameters are reported in the respective figures and figure legends.
Quantification of data used for statistical analysis in this study are described her in detail. For single cell analysis, cell numbers for each time point and subpopulation are as follows: day 0, n = 13,679; day 2, n = 5,905 (n = 2,245 cells in S1, n = 1,994 cells in S2, and n = 1,666 cells in S3); day 5, n = 9,827 (n = 3,850 cells in S1, n = 2,577 cells in S2, n = 2,474 cells in S3, and n = 924 cells in S4); day 15, n = 6,303 (n = 3,520 cells in S1 and n = 2,783 cells in S2); day 30, n = 7,039 (n = 4,038 cells in S1, n = 3,001 cells in S2). For single cell analysis of developing mouse heart ) n = 949 cells from two biological replicates.
For iTranscriptome analysis: E6.5 (n = 6) and E7.5 (n = 6) mouse embryos and published data for E7.0 (n = 3) mouse embryos. Color scales represent levels of expression as log 10 of fragments per kilobase million (FPKM + 1).
For Spearman rank correlation analysis ( Figure 3H ). Values are presented median Spearman's value r. Significant differences between pairs of correlation coefficients were calculated using a Fisher Z-transformation. P-values for all tests were below the double precision limit of 2.2e-308.
For all results n = 3-16 biological replicates from up to 8 independent experiments. Immunohistochemistry morphometric analysis: For Figures 6B and 6C n = 144 cells 16 hours post replating and 77 cells 64 hours post replating. Statistics performed using t test with Welch's correction, p < 0.0001 (****) and p < 0.0009 (***). For Figure 6N n = 57-144 biological replicates per condition for g4 cells and n = 52-78 biological replicates per condition for g1 cells.
DATA AND SOFTWARE AVAILABILITY
scRNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI (https://www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-6268.
